3 companies in RA Capital Management's investment portfolio.
Back to RA Capital Management profile“Science-driven investing in therapeutics companies developing transformative medicines.”
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.
Moderna, Inc. ( mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.
RA Capital Management has built a portfolio of 3 companies across 1 sector, including Biotech.
RA Capital Management has invested in 3+ companies across 1 different sectors.
RA Capital Management's portfolio spans Biotech. This diversification reflects the firm's broad investment thesis and sector expertise.
VentureKit
Turn your thesis into a complete fund launch package — strategy memo, LP pitch deck, financial models, and 11 more custom documents. Generated in 24 hours.
Build Your Fund Package